Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
January-2015 Volume 33 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2015 Volume 33 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Establishment of a Langerhans cell histiocytosis lesion cell line with dermal dendritic cell characteristics

  • Authors:
    • Ichiro Murakami
    • Jean Gogusev
    • Francis Jaubert
    • Michiko Matsushita
    • Kazuhiko Hayashi
    • Ikuo Miura
    • Takehiro Tanaka
    • Takashi Oka
    • Tadashi Yoshino
  • View Affiliations / Copyright

    Affiliations: Division of Molecular Pathology, Faculty of Medicine, Tottori University, Yonago, Tottori 683-8503, Japan, Inserm U507 and U1016, Institut Cochin, 75014 Paris, France, University of Paris Descartes (Paris V), 75006 Paris, France, Department of Pathobiological Science and Technology, School of Health Science, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan, Division of Hematology and Oncology, St. Marianna University School of Medicine Hospital, Kawasaki, Kanagawa 216-8511, Japan, Department of Pathology, Okayama University Hospital, Okayama 700-8530, Japan, Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8530, Japan
  • Pages: 171-178
    |
    Published online on: October 24, 2014
       https://doi.org/10.3892/or.2014.3567
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

A cell line named PRU-1, derived from a Langerhans cell (LC) histiocytosis (LCH) skull lesion of a 7-year-old boy, was established and characterized. PRU-1 is an adherent spindle-shaped cell line that shows no Birbeck granules on electron microscopy. Flow cytometric analysis of cells collected from the early seventh passage showed no LC phenotypes of CD1a and S100 protein. Immunostaining of PRU-1 cells also revealed no expression of LC markers but showed expression of CD11c, CD54 (ICAM-1) and CD68, which was also observed in some peripherally located cells of the original LCH lesion. The PRU-1 cells stained positive for factor XIIIa and negative for CD34, suggesting a dermal dendritic cell phenotype. Cytogenetic analyses revealed abnormalities such as 39,XY,-2,-4,-8,-12,-12,-14,add(18)(q21),20,+mar and 44,XY,-11,-14,add(18)(q21). TCRγ rearrangement in the PRU-1 cells was not amplified by PCR. Tumorigenicity was not proven by xenografting into SCID mice. A conditioned medium from PRU-1 culture induced the proliferation of peripheral blood lymphocytes as well as the activation of monocytes from a healthy donor into CD1a-positive LC-like cells. Because the phenotypic characteristics of PRU-1 differed from those of CD1a-positive abnormal LC-like cells (LCH cells), it was likely that the PRU-1 cells were derived from peripherally located cells of the LCH lesion rather than LCH cells. LCH has been regarded as a type of granulomatous neoplasm with several intermingled inflammatory cells and influenced by stimuli such as Merkel cell polyomavirus (MCPyV) infection or cigarette smoking. However, in the PRU-1 cells, MCPyV-DNA was not detected by PCR. Stromal cell-like PRU-1 cells are likely to produce some growth or differentiation factors, which may play important roles in LCH lesion formation, cell maintenance and LC-like cell induction.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Writing Group of the Histiocyte Society. Lancet. 1:208–209. 1987.PubMed/NCBI

2 

Yousem SA, Dacic S, Nikiforov YE and Nikiforova M: Pulmonary Langerhans cell histiocytosis: profiling of multifocal tumors using next-generation sequencing identifies concordant occurrence of BRAF V600E mutations. Chest. 143:1679–1684. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Badalian-Very G, Vergilio JA, Degar BA, et al: Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 116:1919–1923. 2010. View Article : Google Scholar : PubMed/NCBI

4 

Murakami I, Matsushita M, Iwasaki T, et al: Merkel cell polyomavirus DNA sequences in peripheral blood and tissues from patients with Langerhans cell histiocytosis. Hum Pathol. 45:119–126. 2014. View Article : Google Scholar

5 

Sakata N, Toguchi N, Kimura M, Nakayama M, Kawa K and Takemura T: Development of Langerhans cell histiocytosis associated with chronic active Epstein-Barr virus infection. Pediatr Blood Cancer. 50:924–927. 2008. View Article : Google Scholar

6 

Chen CJ, Ho TY, Lu JJ, et al: Identical twin brothers concordant for Langerhans’ cell histiocytosis and discordant for Epstein-Barr virus-associated haemophagocytic syndrome. Eur J Pediatr. 163:536–539. 2004. View Article : Google Scholar : PubMed/NCBI

7 

Yousem SA, Colby TV, Chen YY, Chen WG and Weiss LM: Pulmonary Langerhans’ cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol. 25:630–636. 2001. View Article : Google Scholar : PubMed/NCBI

8 

Tazi A, Hiltermann JN and Vassallo R: Adult lung histiocytosis. Histiocytic Disorders of Children and Adults. Weitzman S and Egeler RM: Cambridge University Press; Cambridge: pp. 187–207. 2005

9 

Corbeel L, Eggermont E, Desmyter J, et al: Spontaneous healing of Langerhans cell histiocytosis (histiocytosis X). Eur J Pediatr. 148:32–33. 1988. View Article : Google Scholar : PubMed/NCBI

10 

Mogulkoc N, Veral A, Bishop PW, Bayindir U, Pickering CA and Egan JJ: Pulmonary Langerhans’ cell histiocytosis: radiologic resolution following smoking cessation. Chest. 115:1452–1455. 1999. View Article : Google Scholar : PubMed/NCBI

11 

Von Essen S, West W, Sitorius M and Rennard SI: Complete resolution of roentgenographic changes in a patient with pulmonary histiocytosis X. Chest. 98:765–767. 1990. View Article : Google Scholar : PubMed/NCBI

12 

Kawakubo Y, Kishimoto H, Sato Y, et al: Human cytomegalo-virus infection in foci of Langerhans cell histiocytosis. Virchows Arch. 434:109–115. 1999. View Article : Google Scholar : PubMed/NCBI

13 

Leahy MA, Krejci SM, Friednash M, et al: Human herpesvirus 6 is present in lesions of Langerhans cell histiocytosis. J Invest Dermatol. 101:642–645. 1993. View Article : Google Scholar : PubMed/NCBI

14 

Glotzbecker MP, Carpentieri DF and Dormans JP: Langerhans cell histiocytosis: a primary viral infection of bone? Human herpes virus 6 latent protein detected in lymphocytes from tissue of children. J Pediatr Orthop. 24:123–129. 2004. View Article : Google Scholar

15 

Jenson HB, McClain KL, Leach CT, Deng JH and Gao SJ: Evaluation of human herpesvirus type 8 infection in childhood langerhans cell histiocytosis. Am J Hematol. 64:237–241. 2000. View Article : Google Scholar : PubMed/NCBI

16 

Scappaticci S, Danesino C, Rossi E, et al: Cytogenetic abnormalities in PHA-stimulated lymphocytes from patients with Langerhans cell histocytosis. AIEOP-Istiocitosi Group. Br J Haematol. 111:258–262. 2000. View Article : Google Scholar : PubMed/NCBI

17 

Gogusev J, Telvi L, Murakami I, et al: DOR-1, A novel CD10+ stromal cell line derived from progressive Langerhans cell histiocytosis of bone. Pediatr Blood Cancer. 44:128–137. 2005. View Article : Google Scholar

18 

Van Dongen JJ, Langerak AW, Bruggemann M, et al: Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 17:2257–2317. 2003. View Article : Google Scholar : PubMed/NCBI

19 

Kuwamoto S, Higaki H, Kanai K, et al: Association of Merkel cell polyomavirus infection with morphologic differences in Merkel cell carcinoma. Hum Pathol. 42:632–640. 2011. View Article : Google Scholar : PubMed/NCBI

20 

Feldman AL, Berthold F, Arceci RJ, et al: Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis. Lancet Oncol. 6:435–437. 2005. View Article : Google Scholar : PubMed/NCBI

21 

Nezelof C and Basset F: An hypothesis Langerhans cell histiocytosis: the failure of the immune system to switch from an innate to an adaptive mode. Pediatr Blood Cancer. 42:398–400. 2004. View Article : Google Scholar : PubMed/NCBI

22 

Arenzana-Seisdedos F, Barbey S, Virelizier JL, Kornprobst M and Nezelof C: Histiocytosis X. Purified (T6+) cells from bone granuloma produce interleukin 1 and prostaglandin E2 in culture. J Clin Invest. 77:326–329. 1986. View Article : Google Scholar : PubMed/NCBI

23 

Geissmann F, Lepelletier Y, Fraitag S, et al: Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood. 97:1241–1248. 2001. View Article : Google Scholar : PubMed/NCBI

24 

Nezelof C and Basset F: Langerhans cell histiocytosis research. Past, present, and future. Hematol Oncol Clin North Am. 12:385–406. 1998. View Article : Google Scholar : PubMed/NCBI

25 

Aiba S and Tagami H: Phorbol 12-myristate 13-acetate can transform monocyte-derived dendritic cells to different cell types similar to those found in dermatofibroma. A possible in vitro model of the histogenesis of dermatofibroma. J Cutan Pathol. 25:65–71. 1998. View Article : Google Scholar : PubMed/NCBI

26 

Erlandson RA: Ultrastructural features of specific human neoplasms with clinicopathologic, immunohistochemical, and cytogenetic correlations. Diagnostic Transmission Electron Microscopy of Tumors. Raven Press; New York, NY: pp. 243–832. 1994

27 

Weitzman S and Egeler RM: Langerhans cell histiocytosis of bone. Histiocytic Disorders of Children and Adults. Cambridge University Press; Cambridge: pp. 154–173. 2005, View Article : Google Scholar

28 

Lu H, Chen J, Planko L, Zigrino P, Klein-Hitpass L and Magin TM: Induction of inflammatory cytokines by a keratin mutation and their repression by a small molecule in a mouse model for EBS. J Invest Dermatol. 127:2781–2789. 2007.PubMed/NCBI

29 

Egeler RM, Favara BE, van Meurs M, Laman JD and Claassen E: Differential in situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood. 94:4195–4201. 1999.PubMed/NCBI

30 

Raushenbakh MO, Ivanova VD, Shevchenko VE, Makhonova LA and Sergeev AV: Congenital tyrosine metabolism disorders in children with hemoblastoses. Vestn Akad Med Nauk SSSR. 19–24. 1981.(In Russian).

31 

Larrengina AT and Falo LD Jr: Dendritic cells in the context of skin immunity. Dendritic Cells. Lotze MT and Thomson AW: Academic Press; San Diego, CA: pp. 301–314. 2001, View Article : Google Scholar

32 

Betts DR, Leibundgut KE, Feldges A, Pluss HJ and Niggli FK: Cytogenetic abnormalities in Langerhans cell histiocytosis. Br J Cancer. 77:552–555. 1998. View Article : Google Scholar : PubMed/NCBI

33 

Murakami I, Gogusev J, Fournet JC, Glorion C and Jaubert F: Detection of molecular cytogenetic aberrations in langerhans cell histiocytosis of bone. Hum Pathol. 33:555–560. 2002. View Article : Google Scholar : PubMed/NCBI

34 

Arico M, Nichols K, Whitlock JA, et al: Familial clustering of Langerhans cell histiocytosis. Br J Haematol. 107:883–888. 1999. View Article : Google Scholar : PubMed/NCBI

35 

Dufour C, Lanciotti M, Micalizzi C, Valetto A and Haupt R: Non-identical twin sisters concordant for Langerhans cell histiocytosis and discordant for secondary acute promyelocytic leukemia. Med Pediatr Oncol. 37:70–72. 2001. View Article : Google Scholar : PubMed/NCBI

36 

Enjolras O, Leibowitch M, Bonacini F, Vacher-Lavenu MC and Escande JP: Congenital cutaneous Langerhans histiocytosis. Apropos of 7 cases. Ann Dermatol Venereol. 119:111–117. 1992.(In French).

37 

Miyatani K, Takahashi K, Yanai H, Yoshino T and Akagi T: Partial purification and characterization of dendritic cell differentiation factor. Acta Med Okayama. 48:67–72. 1994.PubMed/NCBI

38 

Feng H, Shuda M, Chang Y and Moore PS: Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 319:1096–1100. 2008. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Murakami I, Gogusev J, Jaubert F, Matsushita M, Hayashi K, Miura I, Tanaka T, Oka T and Yoshino T: Establishment of a Langerhans cell histiocytosis lesion cell line with dermal dendritic cell characteristics. Oncol Rep 33: 171-178, 2015.
APA
Murakami, I., Gogusev, J., Jaubert, F., Matsushita, M., Hayashi, K., Miura, I. ... Yoshino, T. (2015). Establishment of a Langerhans cell histiocytosis lesion cell line with dermal dendritic cell characteristics. Oncology Reports, 33, 171-178. https://doi.org/10.3892/or.2014.3567
MLA
Murakami, I., Gogusev, J., Jaubert, F., Matsushita, M., Hayashi, K., Miura, I., Tanaka, T., Oka, T., Yoshino, T."Establishment of a Langerhans cell histiocytosis lesion cell line with dermal dendritic cell characteristics". Oncology Reports 33.1 (2015): 171-178.
Chicago
Murakami, I., Gogusev, J., Jaubert, F., Matsushita, M., Hayashi, K., Miura, I., Tanaka, T., Oka, T., Yoshino, T."Establishment of a Langerhans cell histiocytosis lesion cell line with dermal dendritic cell characteristics". Oncology Reports 33, no. 1 (2015): 171-178. https://doi.org/10.3892/or.2014.3567
Copy and paste a formatted citation
x
Spandidos Publications style
Murakami I, Gogusev J, Jaubert F, Matsushita M, Hayashi K, Miura I, Tanaka T, Oka T and Yoshino T: Establishment of a Langerhans cell histiocytosis lesion cell line with dermal dendritic cell characteristics. Oncol Rep 33: 171-178, 2015.
APA
Murakami, I., Gogusev, J., Jaubert, F., Matsushita, M., Hayashi, K., Miura, I. ... Yoshino, T. (2015). Establishment of a Langerhans cell histiocytosis lesion cell line with dermal dendritic cell characteristics. Oncology Reports, 33, 171-178. https://doi.org/10.3892/or.2014.3567
MLA
Murakami, I., Gogusev, J., Jaubert, F., Matsushita, M., Hayashi, K., Miura, I., Tanaka, T., Oka, T., Yoshino, T."Establishment of a Langerhans cell histiocytosis lesion cell line with dermal dendritic cell characteristics". Oncology Reports 33.1 (2015): 171-178.
Chicago
Murakami, I., Gogusev, J., Jaubert, F., Matsushita, M., Hayashi, K., Miura, I., Tanaka, T., Oka, T., Yoshino, T."Establishment of a Langerhans cell histiocytosis lesion cell line with dermal dendritic cell characteristics". Oncology Reports 33, no. 1 (2015): 171-178. https://doi.org/10.3892/or.2014.3567
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team